Development of a rebamipide solid dispersion system with improved dissolution and oral bioavailability

Archives of Pharmacal Research

Volumn 38, Issue 4, 2015, Pages 522-533

  Pradhan, Roshan ^a   Tran, Tuan Hiep ^a   Choi, Ju Yeon ^a   Choi, Im Soon ^a   Choi, Han Gon ^b   Yong, Chul Soon ^a   Kim, Jong Oh ^a  

^a Yeungnam University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

Bioavailability; Rebamipide; Solid dispersion; Solubility; Spray drying

Indexed keywords

ALANINE; QUINOLONE DERIVATIVE; REBAMIPIDE;

ANALOGS AND DERIVATIVES; ANIMAL; BIOAVAILABILITY; CHEMISTRY; MALE; MEDICINAL CHEMISTRY; PROCEDURES; RAT; SOLUBILITY; SPRAGUE DAWLEY RAT; X RAY DIFFRACTION;

ALANINE; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; MALE; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; X-RAY DIFFRACTION;

EID: 84929624655     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-014-0399-0     Document Type: Article

References (48)

1. Alam, M.A., R. Ali, F.I. Al-Jenoobi, and A.M. Al-Mohizea. 2012. Solid dispersions: A strategy for poorly aqueous soluble drugs and technology updates. Expert Opinion on Drug Delivery 9: 1419-1440.
2. Anderson, N.R., G.S. Banker, and G.E. Peck. 1982. Quantitative evaluation of pharmaceutical effervescent systems I: Design of testing apparatus. Journal of Pharmaceutical Sciences 71: 3-6.
3. Arakawa, T., K. Kobayashi, T. Yoshikawa, and A. Tarnawski. 1998. Rebamipide: overview of its mechanisms of action and efficacy in mucosal protection and ulcer healing. Digestive Diseases and Sciences 43: 5-13.
4. Atkinson, R.M., C. Bedford, K.J. Child, and E.G. Tomich. 1962. The effect of griseofulvin particle size on blood levels in man. Antibiotics and Chemotherapy 12: 232-238.
5. Bassi, P., and G. Kaur. 2010. pH modulation: A mechanism to obtain pH-independent drug release. Expert Opinion on Drug Delivery 7: 845-857.
6. Chaumeil, J.C. 1998. Micronization: A method of improving the bioavailability of poorly soluble drugs. Methods and Findings in Experimental and Clinical Pharmacology 20: 211-215.
7. Chiou, W.L., and S. Reigelman. 1971. Pharmaceutical applications of solid dispersion systems. Journal of Pharmaceutical Sciences 60: 1281-1302.
8. Choi, H., Y. Oh, and C. Kim. 1998. In situ gelling and mucoadhesive liquid suppository containing acetaminophen: Enhanced bioavailability. International Journal of Pharmaceutics 165: 23-32.
9. Choi, H.G., B.J. Lee, C.S. Yong, J.D. Rhee, J.H. Han, M.K. Lee, K.M. Park, and C.K. Kim. 2001. Terfenadine-β-cyclodextrin inclusion complex with the anti-histaminic activity enhancement. Drug Development and Industrial Pharmacy 27: 857-862.
10. Engel, G.L., N.A. Farid, M.M. Faul, L.A. Richardson, and L.L. Winneroski. 2000. Salt form selection and characterization of LY333531 mesylate monohydrate. International Journal of Pharmaceutics 198: 239-247.
11. Fix, J.A. 1987. Absorption enhancing agents for the GI system. Journal Controlled Release 6: 151-156.
12. Fujii, M., H. Okada, Y. Shibata, H. Teramachi, M. Kondoh, and Y. Watanabe. 2005. Preparation, characterization, and tableting of a soild dispersion of indomethacin with Crospovidone. International Journal of Pharmaceutics 293: 145-153.
13. Gibaldi, M., and D. Perrier. 1982. Pharmacokinetics, 2nd ed. New York: Marcel-Dekker.
14. Gupta, M.K., D. Goldman, R.H. Bogner, and Y.C. Tseng. 2001. Enhanced drug dissolution and bulk properties of solid dispersions granulated with a surface adsorbent. Pharmaceutical Development and Technology 6: 563-572.
15. Javaid, K.A., and D.E. Cadwallader. 1972. Dissolution of aspirin from tablets containing various buffering agents. Journal of Pharmaceutical Sciences 61: 1370-1373.
16. Karanth, H., V.S. Shenoy, and R.R. Murthy. 2006. Industrially feasible alternative approaches in the manufacture of solid dispersions: A technical report. AAPS PharmSciTech 87: 31-38.
17. Khalafallah, N., M.W. Gouda, and S.A. Khahl. 1975. Effect of surfactants on absorption through membranes: IV. Effects of dioctylsulfosuccinate on absorption of a poorly absorbable drug in human. Journal of Pharmaceutical Sciences 64: 991-994.
18. Kikuchi, S. 2002. Epidemiology of Helicobacter pylori and gastric cancer. Gastric Cancer 5: 6-15.
19. Li, D., Y. Oh, S. Lim, J. Kim, H. Yang, J. Sung, C. Yong, and H. Choi. 2008. Novel gelatin microcapsule with bioavailability enhancement of ibuprofen using spray-drying technique. International Journal of Pharmaceutics 355: 277-284.
20. Li, J., P. Liu, J.P. Liu, W.L. Zhang, J.K. Yang, and Y.Q. Fan. 2012a. Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: In vitro and in vivo evaluation. European Journal of Pharmaceutics and Biopharmaceutics 80: 426-432.
21. Li, S., C. Pollock-Dove, L.C. Dong, J. Chen, A.A. Creasey, and W.G. Dai. 2012b. Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: A case study. Molecular Pharmaceutics 9: 1100-1108.
22. Lindmark, T., Y. Kimura, and P. Artursson. 1998. Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. Journal of Pharmacology and Experimental Therapeutics 284: 362-369.
23. Marasini, N., T.H. Tran, B.K. Poudel, H.J. Cho, Y.K. Choi, S.C. Chi, H.G. Choi, C.S. Yong, and J.O. Kim. 2013. Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique. International Journal of Pharmaceutics 441: 424-432.
24. Mason, W.D., and N. Winer. 1981. Kinetics of aspirin, salicylic acid and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions. Journal of Pharmaceutical Sciences 70: 262-265.
25. Miyake, M., Y. Oka, T. Minami, H. Toguchi, M. Odomi, K. Ogawara, K. Higaki, and T. Kimura. 2003. Combinatorial use of sodium laurate with taurine or l-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages. Journal of Pharmaceutical Sciences 92: 911-921.
26. Morris, K.R., M.G. Fakes, A.B. Thakur, A.W. Singh, and J.J. Venit. 1994. An integrated approach to the selection of optimal salt form for a new drug candidate. International Journal of Pharmaceutics 105: 209-217.
27. Newa, M., K.H. Bhandari, D.X. Li, T.H. Kwon, J.A. Kim, B.K. Yoo, J.S. Woo, W.S. Lyoo, C.S. Yong, and H.G. Choi. 2007. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. International Journal of Pharmaceutics 343: 228-237.
28. Newa, M., K.H. Bhandari, D.X. Li, J.O. Kim, D.S. Yoo, J.A. Kim, B.K. Yoo, J.S. Woo, W.S. Lyoo, C.S. Yong, and H.G. Choi. 2008. Preparation and evaluation of immediate release ibuprofen solid dispersions using polyethylene glycol 4000. Biological and Pharmaceutical Bulletin 31: 939-945.
29. O'Connor, K.M., and O.I. Corrigan. 2001. Comparison of the physicochemical properties of the N-(2-hydroxyethyl) pyrrolidine, diethylamine and sodium salt forms of diclofenac. International Journal of Pharmaceutics 222: 281-293.
30. Pabari, R.M., and Z. Ramtoola. 2012. Effect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tablets. J. Young Pharmacists 4: 157-163.
31. Prabagar, B., B.K. Yoo, J.S. Woo, J.A. Kim, J.D. Rhee, M.G. Piao, C.S. Yong, and H.G. Choi. 2007. Enhanced bioavailability of poorly water-soluble clotrimazole by inclusion with β-cyclodextrin. Archives of Pharmacal Research 30: 249-254.
32. Rho, J.I. 2003. A new rebamipide lysinate, rebamipide argininate and pharmaceutical preparation containing the same as active substance. Korea Patent 10 2003 0035382.
33. Sekiguchi, K., and N. Obi. 1961. Studies on absorption of eutectic mixtures. I. A comparison of the behavior of eutectic mixtures of sulphathiazole and that of ordinary sulphathiazole in man. Chemical & Pharmaceutical Bulletin 9: 866-872.
34. Seo, S.W., H.K. Han, M.K. Chun, and H.K. Choi. 2012. Preparation and pharmacokinetic evaluation of curcumin solid dispersion using Solutol® HS15 as a carrier. International Journal of Pharmaceutics 424: 18-25.
35. Serajuddin, A.T.M. 1999. Solid dispersion of poorly water-soluble drugs: Early promises, subsequent problems, and recent breakthroughs. Journal of Pharmaceutical Sciences 88: 1058-1066.
36. Sheth, P., H. Sandhu, D. Singhal, W. Malick, N. Shah, and M.S. Kislalioglu. 2012. Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production. Current Drug Delivery 9: 269-284.
37. Shin, B.S., C.H. Kim, Y.S. Jun, C.H. Yoon, J.I. Rho, K.C. Lee, H.S. Han, and S.D. Yoo. 2004. Oral absorption and pharmacokinetics of rebamipide and rebamipide lysinate in rats. Drug Development and Industrial Pharmacy 30: 869-876.
38. Society of Toxicology (SOT). 2008. Guiding Principles in the Use of Animals in Toxicology. www.toxicology.org/AI/FA/guidingprinciples.pdf. Accessed 20 Dec 2013.
39. Tran, P.H., H.T. Tran, and B.J. Lee. 2008. Modulation of microenvironmental pH and crystallinity of ionizable TMS using alkalizers in solid dispersions for controlled release. Journal of Controlled Release 129: 59-65.
40. Tran, P.H., T.T. Tran, K.H. Lee, D.J. Kim, and B.J. Lee. 2010. Dissolution-modulating mechanism of pH modifiers in solid dispersion containing weakly acidic or basic drugs with poor water solubility. Expert Opinion on Drug Delivery 7: 647-661.
41. Tran, H.T.T., J.B. Park, K.H. Hong, H.G. Choi, H.K. Han, J. Lee, K.T. Oh, and B.J. Lee. 2011. Preparation and characterization of pH-independent sustained release tablet containing solid dispersion granules of a poorly water-soluble drug. International Journal of Pharmaceutics 415: 83-88.
42. Tran, T.H., B.K. Poudel, N. Marasini, S.C. Chi, H.G. Choi, C.S. Yong, and J.O. Kim. 2013. Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray drying technique without an organic solvent. International Journal of Pharmaceutics 443: 50-57.
43. Tung, N.T., C.W. Park, T.O. Oh, J.Y. Kim, J.M. Ha, Y.S. Rhee, and E.S. Park. 2011. Formulation of solid dispersion of rebamipide evaluated in a rat model for improved bioavailability and efficacy. Journal of Pharmacy and Pharmacology 63: 1539-1547.
44. US Food and Drug Administration. 2009. Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf. Accessed 15 Jan 2014.
45. Visser, M.R., L. Baert, G.V. Klooster, L. Schueller, M. Geldof, I. Vanwelkenhuysen, H.D. Kock, S.D. Meyer, H.W. Frijlink, J. Rosier, and W.L.J. Hinrichs. 2010. Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240. European Journal of Pharmaceutics and Biopharmaceutics 74: 233-238.
46. Yi, H.G., M.H. Chi, Y.I. Kim, J.S. Woo, and E.S. Park. 2008. Formulation of a extended release tablet containing dexibuprofen. Archives of Pharmacal Research 31: 1637-1643.
47. Yong, C.S., D.X. Li, D.H. Oh, J.A. Kim, B.K. Yoo, J.S. Woo, J.D. Rhee, and H.G. Choi. 2005. Retarded dissolution of ibuprofen in gelatin microcapsule by cross-linking with glutaraldehyde. Archives of Pharmacal Research 29: 431-534.
48. Zhang, Y., J. Zhang, T. Jiang, and S. Wang. 2011. Inclusion of the poorly water-soluble drug simvastatin in mesocellular foam nanoparticles: Drug loading and release properties. International Journal of Pharmaceutics 410: 118-124.